Increasing cholesterol levels in tumor tissues have been attributed to multiple mechanisms, including increased absorption from the circulation, loss of feedback regulation through downregulation of low-density lipoprotein receptors, and upregulation of components of the mevalonate pathway, particularly HMG-CoA reductase [43, 44]. The gene discussed is LDLR; the disease is neoplasm.